To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:
- • State issued document with your organization's Federal Tax ID Number
- • State issued document with your organization's Resale Tax ID Number
- • City or County issued Business License
- • State Department of Health Services License
- • Any other ID issued by the State that includes the business name & address
* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. Avantor will not lift restrictions for residential shipping addresses.
Specifications
- Description:ImmunoCult™ human CD3/CD28 T cell activator
- Size:2 ml
- Environmentally Preferable:
- Cat. No.:MSPP-10971
- Supplier no.:10971
Specifications
About this item
Human T cell activation and expansion reagent. 1×2 ml vial.
Achieve robust activation and expansion of T cells in the absence of magnetic beads, feeder cells, or antigens. This product's gentle activation stimulus ensures a high viability of activated T cells, which can be further expanded in ImmunoCult™-XF T cell expansion medium or other media for culturing human T cells. Antibody complexes bind to and cross-link CD3 and CD28 cell surface ligands, thereby providing the required signals for T cell activation.
ImmunoCult™ Human CD3/CD28 T cell activator can be used on the seahorse XF analyzer to measure T cell activation response and is also available as part of the agilent seahorse XF Hu T cell activation assay kit. This product is designed for cell therapy research applications, but may be qualified for use as an ancillary material (AM) following the framework outlined in USP. STEMCELL can work with you to qualify this reagent as an AM under an approved investigational new drug (IND) or clinical trial application (CTA).